Jim Tananbaum is a renowned entrepreneur and a business leader with more than 25 years of experience in healthcare investing. Jim usually focuses on investment opportunities in the health sector. He is the force behind Foresite Capital, an investment firm that bets on emerging healthcare businesses. He serves as the Chairman, CEO and the President of the company. As the Founder, Jim is responsible for the formulation of Foresite Capital’s investment structure and strategies that have led to its success. Jim also works to ensure all Foresite Capital portfolio companies become established entities. Visit Crunchbase to know more.

Jim’s journey started right after school when he founded GelTex Pharmaceuticals. Through GelTex, Jim introduced two drugs to the market for less than $8 million. The two drugs changed how the pharmaceutical sector dealt with rare diseases and chronic illnesses because they were cheap and more efficient compared other drugs. A few years later, he developed Renzela, a drug that produced more than $200 million in annual revenue. Following this success, GelTex was bought in 1998 in a deal that made Jim a multi-millionaire. GelTex is still a very successful company today. What’s more? GelTex’s leading drug, Renzela, produces close to $1 billion in annual revenue.

After the sale of GelTex, Jim co-founded Theravance pharmaceuticals and become its CEO. The company soon become a force to reckon with and even collaborated with Theravance Biopharma. The two drug companies have a shared market capitalization of about $3 billion. His journey did not end there. The billionaire went on to start Foresite Capital, a company that he uses to bring healthcare innovations to life. As an investor, Jim Tananbaum has helped establish numerous healthcare businesses, which include Amira Pharmaceutical, Healtheon, and Jazz Pharmaceuticals.

Asked what led to the start of Foresite Capital, Jim says his vision of marrying all aspects of his career resulted in the birth of the investment firm. He also says that the need for an innovative investment platform in the healthcare sector pushed him to start Foresite Capital. Jim Tananbaum went to Yale University and received his B.S and B.S.E.E degrees. He also holds an M.D from Harvard and M.S from MIT.

Click here: http://www.massdevice.com/neuropsych-treatment-diagnosis-platform-dev-mindstrong-health-raises-14m-series/